FDA Approves Warning for Carbamazepine; Shire Pharmaceuticals, Validus Pharmaceuticals, Inc., Novartis Corporation Affected

WASHINGTON, Dec. 12 (UPI) -- The U.S. manufacturers of drugs containing carbamazepine have agreed to warn Asian patients to get a genetic blood test before using the medication.

MORE ON THIS TOPIC